Hennig H - Search Results

1

Increased mortality in long-term intensive care patients with active cytomegalovirus infection.

Ziemann M, Sedemund-Adib B, Reiland P, Schmucker P, Hennig H. Ziemann M, et al. Among authors: hennig h. Crit Care Med. 2008 Dec;36(12):3145-50. doi: 10.1097/CCM.0b013e31818f3fc4. Crit Care Med. 2008. PMID: 18936696

2

The impact of donor cytomegalovirus DNA on transfusion strategies for at-risk patients.

Ziemann M, Juhl D, Görg S, Hennig H. Ziemann M, et al. Among authors: hennig h. Transfusion. 2013 Oct;53(10):2183-9. doi: 10.1111/trf.12199. Epub 2013 Apr 15. Transfusion. 2013. PMID: 23581526

3

High prevalence of cytomegalovirus DNA in plasma samples of blood donors in connection with seroconversion.

Ziemann M, Krueger S, Maier AB, Unmack A, Goerg S, Hennig H. Ziemann M, et al. Among authors: hennig h. Transfusion. 2007 Nov;47(11):1972-83. doi: 10.1111/j.1537-2995.2007.01420.x. Transfusion. 2007. PMID: 17958525

4

A novel set of real-time PCRs for rapid differentiation between human cytomegalovirus wild-type and highly passaged laboratory strains.

Ziemann M, Unmack A, Hennig H. Ziemann M, et al. Among authors: hennig h. J Virol Methods. 2010 Dec;170(1-2):155-9. doi: 10.1016/j.jviromet.2010.09.020. Epub 2010 Sep 29. J Virol Methods. 2010. PMID: 20887751

5

Window period donations during primary cytomegalovirus infection and risk of transfusion-transmitted infections.

Ziemann M, Heuft HG, Frank K, Kraas S, Görg S, Hennig H. Ziemann M, et al. Among authors: hennig h. Transfusion. 2013 May;53(5):1088-94. doi: 10.1111/trf.12074. Epub 2013 Jan 16. Transfusion. 2013. PMID: 23320406

6

Evaluation of potentially infectious blood donors in cases of presumed transfusion-transmitted cytomegalovirus infections.

Ziemann M, Hennig H. Ziemann M, et al. Among authors: hennig h. Biol Blood Marrow Transplant. 2014 Apr;20(4):593. doi: 10.1016/j.bbmt.2013.12.572. Epub 2014 Jan 3. Biol Blood Marrow Transplant. 2014. PMID: 24394803 Free article. No abstract available.

7

Prevention of Transfusion-Transmitted Cytomegalovirus Infections: Which is the Optimal Strategy?

Ziemann M, Hennig H. Ziemann M, et al. Among authors: hennig h. Transfus Med Hemother. 2014 Feb;41(1):40-4. doi: 10.1159/000357102. Epub 2013 Dec 19. Transfus Med Hemother. 2014. PMID: 24659946 Free PMC article. Review.

8

Cytomegalovirus Serostatus as Predictor for Adverse Events After Cardiac Surgery: A Prospective Observational Study.

Ziemann M, Heringlake M, Lenor P, Juhl D, Hanke T, Petersen M, Schön J, Heinze H, Groesdonk HV, Paarmann H, Hennig H. Ziemann M, et al. Among authors: hennig h. J Cardiothorac Vasc Anesth. 2017 Dec;31(6):2042-2048. doi: 10.1053/j.jvca.2016.10.024. Epub 2016 Oct 20. J Cardiothorac Vasc Anesth. 2017. PMID: 28073619

9

Infectivity of blood products containing cytomegalovirus DNA: results of a lookback study in nonimmunocompromised patients.

Ziemann M, Juhl D, Brockmann C, Görg S, Hennig H. Ziemann M, et al. Among authors: hennig h. Transfusion. 2017 Jul;57(7):1691-1698. doi: 10.1111/trf.14105. Epub 2017 Mar 28. Transfusion. 2017. PMID: 28370032

10

The natural course of primary cytomegalovirus infection in blood donors.

Ziemann M, Unmack A, Steppat D, Juhl D, Görg S, Hennig H. Ziemann M, et al. Among authors: hennig h. Vox Sang. 2010 Jul 1;99(1):24-33. doi: 10.1111/j.1423-0410.2009.01306.x. Epub 2010 Jan 13. Vox Sang. 2010. PMID: 20074081

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

136 results

Search Page

Filters